Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2020-02-18 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于下属子公司与北京美联泰科生物技术有限公司签署采购协议暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about a related-party transaction involving a subsidiary of the company and another company controlled by related parties. It includes specifics about the procurement agreement, pricing, shareholder structure, board approval, and risk analysis. The document is an announcement of a related-party transaction (关联交易的公告) and does not contain financial statements, audit opinions, or earnings data. It is not a report like an Annual Report or Interim Report, nor is it a call transcript or a dividend notice. It is a regulatory announcement about a capital procurement transaction with related parties, which fits best under the category of Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2020-02-18 Chinese
独立董事关于关联交易事项的独立意见
Governance Information Classification · 95% confidence The document is an independent opinion from independent directors regarding a related-party transaction, referencing regulatory guidelines and company governance rules. It discusses the fairness and legality of a specific transaction and confirms no harm to minority shareholders. This type of document is typically a governance-related disclosure rather than a full financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a call transcript or capital update. It fits best under Governance Information (CGR) as it relates to internal governance and compliance with regulations on related-party transactions.
2020-02-18 Chinese
关于使用闲置募集资金进行现金管理部分到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the use of idle raised funds for cash management, specifically detailing the partial redemption of structured deposits and the status of financial products purchased with raised funds. It includes specific financial figures related to the amounts invested, redeemed, and earnings from these financial products. The document is relatively short (1068 characters) and focuses on the company's management of raised funds rather than presenting a full financial report or earnings release. It is not an annual or interim report, nor is it a call transcript or management report. The content aligns with updates on capital management activities, specifically the use of fundraising proceeds for cash management and related financial transactions. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-02-03 Chinese
关于控股股东部分股权解除质押及再质押的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the partial release and re-pledging of shares by the controlling shareholder of the company. It includes specific data on shareholding percentages, pledge amounts, dates, and financial details related to the pledge and financing arrangements. The content focuses on share pledge and financing activities rather than financial results, management changes, or legal proceedings. It is not a full financial report or earnings release, nor is it a regulatory certification or a report publication announcement. The document fits the category of Capital/Financing Update (CAP) as it provides updates on the company's capital structure changes related to share pledges by the controlling shareholder.
2020-01-21 Chinese
关于持股5%以上股东部分股权质押延期的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the extension of a pledge on shares held by a shareholder owning more than 5% of the company's stock. It details the shareholder's stock pledge amounts, pledge extension dates, and related financial information. The document does not contain financial statements, audit information, or detailed financial results. It is a regulatory announcement about a shareholder's share pledge extension, which fits the category of Regulatory Filings (RNS) as it is a compliance disclosure and does not fit into more specific categories like Capital/Financing Update or Major Shareholding Notification since it focuses on pledge extension rather than share ownership changes or capital raising.
2020-01-08 Chinese
关于下属子公司完成清算注销的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of liquidation and deregistration of two subsidiaries of the company. It provides details about the subsidiaries, their financial status, reasons for liquidation, and the impact on the parent company. There is no indication that this is a full financial report, audit report, or regulatory filing. It is a specific corporate announcement about the status of subsidiaries, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a management change, voting result, or capital change. The document is a formal announcement of a corporate event related to subsidiary liquidation, which is best classified under Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2019-12-25 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.